Page last updated: 2024-08-18

isoquinoline and Leukemia, Myeloid, Acute

isoquinoline has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carter-Cooper, BA; Chang, ET; Choi, EY; Elzey, BD; Lapidus, RG; Larocque, E; Naganna, N; Opoku-Temeng, C; Sintim, HO; Torregrosa-Allen, SE; Wang, M1
Cao, D; Chen, D; Chen, L; Ding, J; Du, Z; Geng, M; Guo, Z; Huang, X; Li, J; Li, Y; Shen, J; Wang, Q; Wang, X; Xiong, B; Xu, X; Yang, H; Zhang, Z; Zheng, X1

Other Studies

2 other study(ies) available for isoquinoline and Leukemia, Myeloid, Acute

ArticleYear
Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice.
    EBioMedicine, 2019, Volume: 40

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; fms-Like Tyrosine Kinase 3; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Mice; Molecular Structure; Mutation; Naphthyridines; Protein Kinase Inhibitors; src-Family Kinases

2019
Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia.
    Journal of medicinal chemistry, 2019, 06-13, Volume: 62, Issue:11

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Enzyme Inhibitors; G1 Phase Cell Cycle Checkpoints; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Protein Conformation; Protein-Arginine N-Methyltransferases; Stereoisomerism; Tissue Distribution; Xenograft Model Antitumor Assays

2019